Vanguard FTSE Developed Europe ex UK UCITS ETF Distributing (GBP) | VERXRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 8.3 | 17.2 | -7.8 | 15.4 | 4.7 | |
+/-Cat | -1.0 | 1.8 | 0.9 | 1.8 | 2.2 | |
+/-B’mrk | 0.4 | -0.1 | -0.3 | 0.4 | 0.2 | |
Category: Europe ex-UK Equity | ||||||
Category Benchmark: Morningstar DM Eur xUK TME ... |
Key Stats | ||
Closing Price 20/11/2024 | GBX 3222.00 | |
Day Change | 20.71% | |
Morningstar Category™ | Europe ex-UK Equity | |
Volume | 142715 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00BKX55S42 | |
Fund Size (Mil) 21/11/2024 | EUR 2577.98 | |
Share Class Size (Mil) 21/11/2024 | EUR 2035.02 | |
Ongoing Charge 05/03/2024 | 0.10% |
Investment Objective: Vanguard FTSE Developed Europe ex UK UCITS ETF Distributing (GBP) | VERX |
This Fund seeks to track the performance of the Index, a widely recognised market- capitalization weighted index of stock market performance of European developed countries, excluding the United Kingdom, that is comprised of the stocks of large and mid capitalisation companies in that region. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Not Disclosed 30/09/2014 | ||
Inception Date 30/09/2014 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE Developed Europe ex UK NR EUR | Morningstar DM Eur xUK TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Vanguard FTSE Developed Europe ex UK UCITS ETF Distributing (GBP) | VERX | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 4.05 |
ASML Holding NV | Technology | 3.13 |
SAP SE | Technology | 3.02 |
Nestle SA | Consumer Defensive | 2.87 |
Novartis AG Registered Shares | Healthcare | 2.61 |
Increase Decrease New since last portfolio | ||
Vanguard FTSE Developed Europe ex UK UCITS ETF Distributing (GBP) | VERX |